Manufacturing

Suzanne Shelley is a contributing editor to 

Articles

Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve. 

Safeguarding Biologics— Blending Engineering Ingenuity  and Managerial Excellence

Thermo Fisher Scientific’s new facility in Hangzhou, China, is designed to boost biologics and sterile development and manufacturing capabilities in the Asia-Pacific region.

Thermo Fisher Expands Biologics and Steriles Manufacturing Capabilities in China

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Digitalization of bioprocessing is slowly bringing benefits to the biopharma industry.

Digitalization of Biomanufacturing: A Status Update

High-cost-per-dose large molecules can make a big impact on cell and gene therapy supply chain management.

Drug Product Security

Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.

Scorpion Biological Services Opens San Antonio Biologics Facility

 Washington Editor, jillwechsler7@gmail.com.

CBER maps modernization plan to handle surge in research and applications. 

FDA Expands Oversight of Cell and Gene Therapies

Meg Rivers is the former senior editor for 

Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.

Deciding Where to Outsource in Biopharma Development and Manufacturing

WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.

WuXi STA Opens a New Large-Scale Continuous Manufacturing Plant

MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.

MilliporeSigma to Supply Lotte Biologics with Biologics Manufacturing Capabilities in US

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Manufacturing, Biologics